Status | Study |
Enrolling by invitation |
Study Name: Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET) Condition: Eosinophilic Esophagitis Date: 2016-03-24 Interventions: Device: Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy A nove |
Active, not recruiting |
Study Name: Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety Condition: Erosive Esophagitis Date: 2016-02-08 Interventions: Drug: Vonoprazan Vonoprazan fu |
Active, not recruiting |
Study Name: The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis Condition: Eosinophilic Esophagitis Date: 2015-01-26 Interventions: Drug: Sucralfate Sucralfate sl |
Recruiting |
Study Name: Fibrostenotic Eosinophilic Esophagitis: Assessment Tools Condition: Eosinophilic Esophagitis Date: 2014-09-16 |
Active, not recruiting |
Study Name: Mucosal Impedance and Eosinophilic Esophagitis Condition: Eosinophilic Esophagitis Date: 2013-09-26 Interventions: Device: Mucosal Impedance Mucosal impedance- a (tiny tube) |
Completed |
Study Name: Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients Condition: Eosinophilic Esophagitis Date: 2012-07-10 Interventions: Other: Absorbable sugars Lactulose (1,000 mg) and mannitol (200 mg). For the liquid formulation, these s |
Terminated |
Study Name: A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children Condition: Eosinophilic Esophagitis Date: 2011-10-18 Interventions: Drug: Montelukast Those in Mon |
Completed |
Study Name: Eosinophilic Esophagitis Databank Condition: Esophagitis Eosinophilic Esophagitis Date: 2011-03-24 |
Completed |
Study Name: Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis Condition: Eosinophilic Esophagitis Date: 2010-07-23 Interventions: Device: NIOX MINO® Airway Inflammation Monitor We will measure exhaled nitric oxide of patients wit |
Completed |
Study Name: Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) Condition: Eosinophilic Esophagitis Date: 2009-08-14 Interventions: Drug: inhaled/swallowed budesonide |